0001209191-21-063235.txt : 20211105 0001209191-21-063235.hdr.sgml : 20211105 20211105172339 ACCESSION NUMBER: 0001209191-21-063235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211105 DATE AS OF CHANGE: 20211105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 211385778 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-01 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2021-10-01 4 P 0 142 2.69 A 40937 D Common Stock 2021-10-04 4 P 0 142 2.87 A 41079 D Common Stock 2021-10-05 4 P 0 142 2.82 A 41221 D Common Stock 2021-10-06 4 P 0 142 2.76 A 41363 D Common Stock 2021-10-07 4 P 0 142 2.76 A 41505 D Common Stock 2021-10-08 4 P 0 142 2.84 A 41647 D Common Stock 2021-10-11 4 P 0 142 2.73 A 41789 D Common Stock 2021-10-12 4 P 0 142 2.71 A 41931 D Common Stock 2021-10-13 4 P 0 142 2.71 A 42073 D Common Stock 2021-10-14 4 P 0 142 2.81 A 42215 D Common Stock 2021-10-15 4 P 0 142 2.76 A 42357 D Common Stock 2021-10-18 4 P 0 142 2.75 A 42499 D Common Stock 2021-10-19 4 P 0 142 2.76 A 42641 D Common Stock 2021-10-20 4 P 0 142 2.63 A 42783 D Common Stock 2021-10-21 4 P 0 142 2.65 A 42925 D Common Stock 2021-10-22 4 P 0 142 2.66 A 43067 D Common Stock 2021-10-25 4 P 0 142 2.64 A 43209 D Common Stock 2021-10-26 4 P 0 142 2.64 A 43351 D Common Stock 2021-10-27 4 P 0 142 2.61 A 43493 D Common Stock 2021-10-28 4 P 0 142 2.61 A 43635 D Common Stock 2021-10-29 4 P 0 142 2.72 A 43777 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Joseph C. Galante by /s/ John Hamm as attorney-in-fact 2021-11-05